| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth S Thomson | |
| Ellen S Moland | |||
| Nancy E Cornish | |||
| Christian Herdt | |||
| Kim Hemrick | |||
| Seong G Hong | |||
| P2860 | cites work | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 |
| Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates | Q44342622 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
| Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. | Q33976916 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Controversies about extended-spectrum and AmpC beta-lactamases | Q34213755 | ||
| Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center | Q34370760 | ||
| Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support | Q34647842 | ||
| Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method | Q34974437 | ||
| Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 | Q35073335 | ||
| More extended-spectrum beta-lactamases | Q37520309 | ||
| Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates | Q38475591 | ||
| Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital | Q39465236 | ||
| Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City | Q39687830 | ||
| Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York | Q41003539 | ||
| Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection | Q42054277 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 2380-2384 | |
| P577 | publication date | 2007-06-27 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases | |
| P478 | volume | 45 |
| Q35019487 | Biosensor diagnosis of urinary tract infections: a path to better treatment? |
| Q36870786 | Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy |
| Q33623060 | Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems |
| Q91727179 | Clinical Validation of Innovative Optical-Sensor-Based, Low-Cost, Rapid Diagnostic Test to Reduce Antimicrobial Resistance |
| Q34741114 | Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. |
| Q38869114 | Development of a rapid diagnostic assay based on magnetic bead purification of OXA-β-lactamase mRNA. |
| Q39762100 | Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms |
| Q54369631 | Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods. |
| Q83341760 | Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes |
| Q35090146 | Expert systems in clinical microbiology |
| Q43248345 | Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium |
| Q33769534 | Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues |
| Q36261351 | High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain |
| Q43716670 | Metallo-β-lactamase-producing Enterobacteriaceae isolates at a Taiwanese hospital: lack of distinctive phenotypes for screening |
| Q33806235 | New and developing diagnostic technologies for urinary tract infections |
| Q33920474 | Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers |
| Q33960560 | Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay |
| Q38804199 | Whole Genome Sequencing Accurately Identifies Resistance to Extended Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens. |
Search more.